CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(01): 29-33
DOI: 10.4103/ijmpo.ijmpo_113_19
Original Article

Acute Leukemia Presenting with Musculoskeletal Manifestations: A Case Series

Swetha Kesarapu
Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Navatha Vangala
Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Shantveer G Uppin
Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Megha S Uppin
Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Tara Roshni Paul
Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Liza Rajasekhar
Department of Rheumatology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Introduction: Leukemia is the most common childhood malignancy accounting for 30%–40% of cases. Acute lymphoblastic leukemia is the most common leukemia in children with peak incidence in 2–6 years of age. The present study aims to assess the incidence of acute leukemia in patients presenting with musculoskeletal manifestations. Materials and Methods: This is a retrospective study conducted in a tertiary center from January 2014 to December 2018. A total of 63 children presented with musculoskeletal manifestations and underwent bone marrow examination. Based on final marrow diagnosis, the study group was divided into leukemic and nonleukemic groups. Results: Fever was the most common presenting complaint and was present in all the patients of both the groups. The occurrence of hepatosplenomegaly was comparatively higher in the leukemic group than in patients with juvenile idiopathic arthritis (JIA). The predominant type of arthritis was oligoarticular (68.15%) in the leukemic group and polyarticular (77.27%) in the nonleukemic group. Rheumatoid rash was noted in 20% of JIA patients, and none of the patients in the leukemic group had rash. The percentages of anemia, leukopenia, and thrombocytopenia were statistically higher in leukemia patients than in JIA patients. Conclusion: Bone marrow studies are a prerequisite in diagnosing leukemias. However, based on the presence of few atypical clinical and laboratory features, leukemia can be excluded in JIA patients.



Publication History

Received: 07 May 2019

Accepted: 12 July 2019

Article published online:
23 May 2021

© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008; 112: 416-32
  • 2 de Camargo B, de Oliveira Santos M, Rebelo MS, de Souza Reis R, Ferman S, Noronha CP. et al. Cancer incidence among children and adolescents in Brazil:First report of 14 population-based cancer registries. Int J Cancer 2010; 126: 715-20
  • 3 Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58: 15-25
  • 4 Barr R, Riberio R, Agarwal B, Masera G, Hesseling P, Magrath I. Pediatric oncology in countries with limited resources. In: Pizzo PA, Poplack DG. editors Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006: 1605-17
  • 5 Bashar A. Incidence and pattern of childhood cancers in India: Findings from population-based cancer registries. Indian J Cancer 2016; 53: 511-2
  • 6 Barbosa CM, Nakamura C, Terreri MT, Lee ML, Petrilli AS, Hilário MO. Musculoskeletal manifestations as the onset of acute leukemias in childhood. J Pediatr (Rio J) 2002; 78: 481-4
  • 7 Robazzi TC, Barreto JH, Silva LR, Santiago MB, Mendonça N. Osteoarticular manifestations as initial presentation of acute leukemias in children and adolescents in Bahia, Brazil. J Pediatr Hematol Oncol 2007; 29: 622-6
  • 8 Campos LM, Goldstein S, Santiago RA, Jesus AA, Cristofani LM, Odone Filho V. et al. Musculoskeletal involvement as a first manifestation of neoplasm disease. Rev Assoc Med Bras (1992) 2008; 54: 132-8
  • 9 Schaller J. Arthritis as a presenting manifestation of malignancy in children. J Pediatr 1972; 81: 793-7
  • 10 Saulsbury FT, Sabio H. Acute leukemia presenting as arthritis in children. Clin Pediatr (Phila) 1985; 24: 625-8
  • 11 Goncalves M, Terreri MT, Barbosa CM, Len CA, Lee L, Hilario MO. Diagnosis of malignancies in children with musculoskeletal complaints. Sao Paulo Med J 2005; 123: 21-3
  • 12 Murray MJ, Tang T, Ryder C, Mabin D, Nicholson JC. Childhood leukaemia masquerading as juvenile idiopathic arthritis. BMJ 2004; 329: 959-61
  • 13 Tafaghodi F, Aghighi Y, Rokni Yazdi H, Shakiba M, Adibi A. Predictive plain X-ray findings in distinguishing early stage acute lymphoblastic leukemia from juvenile idiopathic arthritis. Clin Rheumatol 2009; 28: 1253-8
  • 14 Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: Diagnostic pitfall and association with survival. Ann Hematol 2010; 89: 249-54
  • 15 Lovell DJ. Juvenile idiopathic arthritis: Clinical features. In: Kippel JH, Stone JH, Crofford LJ, White PH. editors Primer on the Rheumatic Diseases. 13th ed. New York: Springer Science; 2008
  • 16 Simard JF, Neovius M, Hagelberg S, Askling J. Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study. Arthritis Rheum 2010; 62: 3776-82
  • 17 Yanagimachi M, Miyamae T, Naruto T, Hara T, Kikuchi M, Hara R. et al. Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis. J Hum Genet 2011; 56: 196-9
  • 18 Tamashiro MS, Aikawa NE, Campos LM, Cristofani LM, Odone-Filho V, Silva CA. Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset. Clinics (Sao Paulo) 2011; 66: 1665-9
  • 19 Brix N, Rosthøj S, Herlin T, Hasle H. Arthritis as presenting manifestation of acute lymphoblastic leukaemia in children. Arch Dis Child 2015; 100: 821-5
  • 20 Mulder H, Herregods N, Mondelaers V, Benoit Y, De Moerloose B. Musculoskeletal manifestations in children with acute lymphoblastic leukaemia. Belg J Hematol 2012; 3: 3-11
  • 21 Jali S, Prashanth GP, Amarkhed P. Migratory polyarthritis in aleukemic lymphoblastic leukemia: An undesignated paraneoplastic syndrome. J Sci Soc 2013; 40: 44-6
  • 22 Wallendal M, Stork L, Hollister JR. The discriminating value of serum lactate dehydrogenase levels in children with malignant neoplasms presenting as joint pain. Arch Pediatr Adolesc Med 1996; 150: 70-3
  • 23 Jones OY, Spencer CH, Bowyer SL, Dent PB, Gottlieb BS, Rabinovich CE. A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis. Pediatrics 2006; 117: e840-4